Red Tree Venture Capital Fund II
Share
N°01 / About
About Red Tree Venture Capital Fund II
West Coast-centric, early stage-biased life science VC focused on first-in-class and/or best-in-class therapeutics in oncology, neurology and immunology, sourcing from leading West Coast academic and research institutions.
N°02 / Thesis
Investment Focus
Location / RegionUnited States
Funding StageSeed
Industry Focus
Biotech
MedTech
Therapeutics
Investor Signals Profile
active
Sweet Spot
Pioneering entrepreneurs developing first-in-class or best-in-class therapeutics and ground-breaking technology platforms.
18 signals on Red Tree Venture Capital Fund II
4 bullish · 2 contrarian · 5 pitch do's · 3 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.